Reliv' International, Inc. (RELV) is a Major Pharmaceuticals company listed on NASDAQ. There were no new wire items for RELV in the last 30 days. The most recent was published Jan 19, 2021.
Latest news
7 items- SECSEC Form 15-12G filed15-12G - RELIV INTERNATIONAL INC (0000768710) (Filer)
- SECSEC Form SC 13E3/A filedSC 13E3/A - RELIV INTERNATIONAL INC (0000768710) (Subject)
- SECSEC Form 8 filed8-K - RELIV INTERNATIONAL INC (0000768710) (Filer)
- SECSEC Form 2 filed25 - RELIV INTERNATIONAL INC (0000768710) (Filer)
- PRReliv International, Inc. Announces Update to its Reverse Stock Split Transaction and Plan to Delist from NASDAQ and Deregister its Common StockCHESTERFIELD, Mo., Dec. 4, 2020 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, today announced an update to its plan to suspend its obligations to file periodic and current reports and other information with the U.S. Securities and Exchange Commission (the "Commission") under the Securities Exchange Act of 1934, as amended (the "Exchange Act") and to delist its common stock from trading on the NASDAQ Stock Exchange as previously announced in a press release on October 19, 2020. December 21, 2020 will be the effective date of the Company's 1-for-2,000 reverse stock split (the "Reverse Split") of its
- PRReliv International Reports Third-Quarter Financial Results for 2020CHESTERFIELD, Mo., Nov. 13, 2020 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a marketer of nutritional supplements that promote optimal health, today reported its financial results for the third quarter of 2020. Reliv reported net sales of $8.7 million for the third quarter of 2020 compared with net sales of $9.1 million in the third quarter of 2019, a decrease of 5.3%. Net sales in the United States, our largest market, decreased by $161,000 in the third quarter of 2020, which represented a 2.4% decrease in net sales when compared to the prior-year quarter. In the third quarter of 2019, net sales in the United States were favorably impacted by the then-recent launch of the R
- PRReliv International, Inc. Announces Reverse Stock Split Transaction And Plan To Delist From NASDAQ And Deregister Its Common StockCHESTERFIELD, Mo., Oct. 19, 2020 /PRNewswire/ -- Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, today announced that it will effect a 1 for 2,000 reverse stock split (the "Reverse Split") of its Common Stock followed immediately by a 2,000 for 1 forward stock split (the "Forward Split") of its Common Stock (collectively the "Stock Split"). The Stock Split has been approved by written consent of holders of a majority of the Company's outstanding Common Stock. Interests in fractional shares owned by stockholders owning fewer than 2,000 shares of Common Stock will be converted into the right to receive a cash payment
RELV FAQ
7 questionsWhat does Reliv' International, Inc. do?
Reliv' International, Inc. develops and markets nutritional supplements that address basic nutrition, specific wellness needs, weight management, and sports nutrition. The company's basic nutritional supplements are formulated to provide a balanced and complete level of supplementation for the consumer. Its principal products include Reliv Classic, Reliv Now, Innergize!, and FibRestore along with LunaRich X capsules. The company markets and sells its products through a direct selling system of independent distributors in the United States, Australia, Austria, Canada, France, Germany...What is the latest news on RELV?
Quantisnow has not tracked any new filings, ratings or press releases for RELV in the last 30 days. The most recent wire item was published on January 19, 2021.Where does RELV stock trade?
Reliv' International, Inc. (RELV) is listed on NASDAQ.What sector and industry is RELV in?
Reliv' International, Inc. operates in the Health Care sector, Major Pharmaceuticals industry.When did Reliv' International, Inc. go public?
Reliv' International, Inc. (RELV) completed its IPO in n/a.What companies are similar to RELV?
Notable peers in the same industry include ADMS (Adamas Pharmaceuticals, Inc.), ADRO (Aduro Biotech, Inc.), ADXS (Advaxis, Inc.), ARPO (Aerpio Pharmaceuticals, Inc.), AIMT (Aimmune Therapeutics, Inc.). Compare RELV side-by-side with any of them on Quantisnow.How can I track RELV on Quantisnow?
Quantisnow aggregates Reliv' International, Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RELV to receive live email and push alerts on every new disclosure.